| Literature DB >> 31126290 |
Haitao Guan1, Jun Fu1, Xiang Li2, Wei Chai1, Libo Hao1, Rui Li1, Jing Zhao3, Jiying Chen4.
Abstract
BACKGROUND: Periprosthetic joint infection (PJI) is a devastating complication following total joint arthroplasty (TJA). Now, the definition of PJI traditionally used in clinical practice was set out by the International Consensus Meeting (ICM) and Infectious Diseases Society (IDSA). There was a new definition proposed in May 2018 on a paper published in the Journal of Arthroplasty. The new scoring system for PJI demonstrated a higher sensitivity and specificity than Musculoskeletal Infection Society and IDSA criteria. Therefore, we wanted to find further evidence to support the new definition in the Chinese population.Entities:
Keywords: Chinese population; Diagnosis; New definition; Periprosthetic joint infection
Mesh:
Year: 2019 PMID: 31126290 PMCID: PMC6534864 DOI: 10.1186/s13018-019-1185-y
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
New scoring based definition for periprosthetic joint infection (PJI)
Proceed with caution in: adverse local tissue reaction, crystal deposition disease, slow growing organisms
*For patients with inconclusive minor criteria, operative criteria can also be used to fulfill definition for PJI
**Consider further molecular diagnostics such as next-generation sequencing
Demographics of patients in PJI cohort (n = 98) and aseptic cohort (n = 165)
| Variable | Overall ( | PJI cohort ( | Aseptic cohort ( | |
|---|---|---|---|---|
| Age | 61.4 (12.1) | 63.1 (13.5) | 60.4 (14.1) | 0.084 |
| Gender (male) | 116 (44.1%) | 47 (48.0%) | 69 (41.8%) | 0.332 |
| Joint (knee) | 75 (28.5%) | 40 (40.8%) | 35 (21.2%) | 0.001* |
| Time from last surgery (yr) | 8.4 (5.9) | 4.1 (4.5) | 10.2 (6.8) | < 0.001* |
| Most recent surgery a revision procedure | 51 (19.4%) | 27 (27.6%) | 24 (14.5%) | 0.01* |
| History of rheumatoid arthritis and ankylosing spondylitis | 24 (9.1%) | 5 (5.1%) | 19 (11.5%) | 0.081 |
| History of malignancy | 12 (4.6%) | 3 (3.1%) | 9 (5.5%) | 0.368 |
| History of diabetes | 39 (14.8%) | 21 (21.4%) | 18 (10.9%) | 0.02* |
Quantitative data is presented as mean (standard deviation). Qualitative data is presented as number (%)
yr year
*p < 0.05: statistically significant
The comparison of diagnostic outcome between the new criteria and the classical criteria by the International Consensus Meeting (ICM) and Infectious Diseases Society of America (IDSA)
| PJI cohort ( | Aseptic cohort ( | Sensitivity (95% CI) | Specificity (95% CI) | PV+ (95% CI) | PV− (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| True positives | False negatives | Inconclusive | True negative | False positives | Inconclusive | |||||
| New criteria | 78 (79.6%) | 5 (5.1%) | 15 (15.3%) | 145 (87.9%) | 8 (4.8%) | 12 (7.3%) | 94.9% (87.9–98.1%) | 95.2% (90.3–97.7%) | 92.1% (84.5–96.3%) | 96.9% (92.6–98.9%) |
| ICM (2013) | 52 (53.1%) | 46 (46.9%) | / | 163 (98.8%) | 2 (1.2%) | / | 53.1% (42.8–63.1%) | 98.8% (95.2–99.8%) | 96.3% (86.2–99.4%) | 78.0% (71.6–83.3%) |
| IDSA (2013) | 71 (72.4%) | 27 (27.6%) | / | 143 (86.7%) | 22 (13.3%) | / | 72.4% (62.3–80.8%) | 86.7% (80.3–91.3%) | 76.3% (66.2–84.3%) | 84.1% (77.6–89.1%) |